A detailed history of Northstar Advisory Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Northstar Advisory Group, LLC holds 439 shares of LLY stock, worth $398,045. This represents 0.21% of its overall portfolio holdings.

Number of Shares
439
Previous 492 10.77%
Holding current value
$398,045
Previous $286,000 19.23%
% of portfolio
0.21%
Previous 0.17%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$592.2 - $792.28 $31,386 - $41,990
-53 Reduced 10.77%
439 $341,000
Q4 2023

Jan 18, 2024

BUY
$525.19 - $619.13 $1,050 - $1,238
2 Added 0.41%
492 $286,000
Q3 2023

Oct 12, 2023

SELL
$434.7 - $599.3 $196,919 - $271,482
-453 Reduced 48.04%
490 $263,000
Q2 2023

Jul 13, 2023

SELL
$350.74 - $468.98 $585,735 - $783,196
-1,670 Reduced 63.91%
943 $442,000
Q1 2023

Apr 10, 2023

SELL
$310.63 - $364.82 $563,482 - $661,783
-1,814 Reduced 40.98%
2,613 $897,000
Q4 2022

Jan 24, 2023

BUY
$321.55 - $374.67 $270,745 - $315,472
842 Added 23.49%
4,427 $0
Q3 2022

Oct 14, 2022

BUY
$296.48 - $337.87 $435,825 - $496,668
1,470 Added 69.5%
3,585 $1.16 Million
Q2 2022

Jul 11, 2022

SELL
$278.73 - $327.27 $9,198 - $10,799
-33 Reduced 1.54%
2,115 $686,000
Q1 2022

Apr 14, 2022

SELL
$234.69 - $291.66 $82,376 - $102,372
-351 Reduced 14.05%
2,148 $615,000
Q4 2021

Jan 20, 2022

BUY
$224.85 - $279.04 $561,900 - $697,320
2,499 New
2,499 $690,000
Q3 2021

Oct 14, 2021

SELL
$221.6 - $272.71 $479,320 - $589,871
-2,163 Closed
0 $0
Q2 2021

Jul 20, 2021

BUY
$180.55 - $233.54 $41,345 - $53,480
229 Added 11.84%
2,163 $496,000
Q1 2021

Apr 26, 2021

SELL
$164.32 - $212.72 $16,596 - $21,484
-101 Reduced 4.96%
1,934 $361,000
Q4 2020

Jan 19, 2021

BUY
$130.46 - $172.63 $265,486 - $351,302
2,035 New
2,035 $344,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $862B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Northstar Advisory Group, LLC Portfolio

Follow Northstar Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northstar Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Northstar Advisory Group, LLC with notifications on news.